Nilotinib in patients with Ph+ chronic myeloid leukemia in accelerated phase following imatinib resistance or intolerance: 24-month follow-up results

P. le Coutre, F. Giles, A Hochhaus, J. Apperley, G.J. Ossenkoppele, R. Blakesley, Y. Shou, N. Gallagher, M. Baccarani, J. Cortes, H. Kantarjian

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)1189-1194
JournalLeukemia
Volume26
Issue number6
DOIs
Publication statusPublished - 2012

Cite this